CMSC INforMS: OHSU doctors part of 'breakthrough' research on treating multiple sclerosis
Friday, April 19, 2019
Posted by: Elizabeth Porco
PORTLAND, Ore. (KATU) – They're calling it a potential game-changer.
Doctors at Oregon Health and Science University are part of a new breakthrough in research on multiple sclerosis.
Researchers say they've developed a compound that can lead to the repair of a protective cover for cells in the brain and spine. That cover, called myelin, is often damaged in patients diagnosed with MS.
Two of the senior authors involved in the study say the drug they helped create is a first for the treatment of multiple sclerosis.
"There are no known drugs currently available that stimulate myelin. That's the one big problem remaining with ms therapy,” said Tom Scanlan, Ph.D. at OHSU.
Doctor Dennis Bourdette said he expects it will be a few years before the compound is ready for clinical trials. You can read more about the research on OHSU's website.
There is no known cure for multiple sclerosis.
The industry news information and articles are for informational purposes only, and are not intended to represent any trends, partnerships, commitments, or research of the Consortium of MS Centers or any of it's members in any way whatsoever, nor should any party be libel in any way to the reader or to any other person, firm or corporation reading this industry news section. Although the CMSC site includes links providing direct access to other Internet sites, CMSC takes no responsibility for the content or information contained on those other sites, and does not exert any editorial or other control over those other sites. CMSC is providing information and services on the Internet as a benefit and service in furtherance of CMSC's nonprofit and tax-exempt status. CMSC makes no representations about the suitability of this information and these services for any purpose.